PS Ratio: 44.90

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 44.90 is 564% above its estimated 3-year average of 6.76, around the middle of its estimated 3-year range (1.38–70.10).

As of 2026-10-06T21:34:17.849Z. 55.14% above its estimated 12-month average of 28.94.

TRDA PS Ratio Metrics

P/S vs. estimated history

At 44.90, P/S is above its estimated 3-year median — higher than 89% of readings in its estimated 3-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Entrada Therapeutics, Inc. (TRDA)?

The P/S ratio for TRDA stock is 44.90.

Is Entrada Therapeutics, Inc.'s P/S ratio high or low?

The P/S ratio of 44.90 is 564% above its estimated 3-year average of 6.76, around the middle of its estimated 3-year range (1.38–70.10).

What is the estimated TTM average P/S ratio for Entrada Therapeutics, Inc. (TRDA)?

The estimated TTM average P/S ratio for TRDA stock is 28.94.

What is the estimated 3Y average P/S ratio for Entrada Therapeutics, Inc. (TRDA)?

The estimated 3Y average P/S ratio for TRDA stock is 4.04.

Showing the most recent 260 of 853 data points. The chart above shows the full history.

Related Metrics